{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:44:45Z","timestamp":1791582285231,"version":"4.3.4"},"reference-count":40,"publisher":"Japanese Association for Laboratory Animal Science","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1538\/expanim.25-0061","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T22:07:10Z","timestamp":1752876430000},"page":"40-49","source":"Crossref","is-referenced-by-count":1,"title":["A partial deletion of the &lt;i&gt;Tardbp&lt;\/i&gt; 3\u2019UTR affects TDP-43 regulation and leads to motor dysfunction in mice"],"prefix":"10.1538","volume":"75","author":[{"given":"Tra Thi Huong","family":"Dinh","sequence":"first","affiliation":[{"name":"Next Generation Human Disease Model Research Team, RIKEN BioResource              Research Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chigusa","family":"Imura","sequence":"additional","affiliation":[{"name":"Next Generation Human Disease Model Research Team, RIKEN BioResource              Research Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Shiokawa","sequence":"additional","affiliation":[{"name":"Next Generation Human Disease Model Research Team, RIKEN BioResource              Research Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ayabe","sequence":"additional","affiliation":[{"name":"Experimental Animal Division, RIKEN BioResource Research Center, 3-1-1              Koyadai, Tsukuba, Ibaraki 305-0074, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yoshiki","sequence":"additional","affiliation":[{"name":"Experimental Animal Division, RIKEN BioResource Research Center, 3-1-1              Koyadai, Tsukuba, Ibaraki 305-0074, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhisa","family":"Inoue","sequence":"additional","affiliation":[{"name":"iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research              Center, 1-7 Hikaridai, Seika-cho, Soraku-gun, Kyoto 619-0237, Japan"},{"name":"Center for iPS Cell Research and Application (CiRA), Kyoto University, 53              Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan"},{"name":"Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced              Intelligence Project (AIP), 53 Shogoin Kawahara, Sakyo, Kyoto 606-8507,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Amano","sequence":"additional","affiliation":[{"name":"Next Generation Human Disease Model Research Team, RIKEN BioResource              Research Center, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Feldman              EL, Goutman              SA, Petri              S, Mazzini              L, Savelieff              MG, Shaw              PJ, et            al. Amyotrophic lateral sclerosis.            Lancet. 2022; 400:            1363\u20131380.","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hardiman              O, Al-Chalabi              A, Chio              A, Corr              EM,                Logroscino              G, Robberecht              W, et            al. Amyotrophic lateral sclerosis.            Nat Rev Dis Primers. 2017; 3:            17085.","DOI":"10.1038\/nrdp.2017.71"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kiernan              MC, Vucic              S, Cheah              BC, Turner              MR, Eisen              A, Hardiman              O, et            al. Amyotrophic lateral sclerosis.            Lancet. 2011; 377:            942\u2013955.","DOI":"10.1016\/S0140-6736(10)61156-7"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Sreedharan              J, Blair              IP, Tripathi              VB, Hu              X, Vance              C, Rogelj              B, et            al. TDP-43 mutations in familial and sporadic            amyotrophic lateral sclerosis. Science.            2008; 319: 1668\u20131672.","DOI":"10.1126\/science.1154584"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Suk              TR, Rousseaux              MWC. The role            of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol            Neurodegener. 2020; 15: 45.","DOI":"10.1186\/s13024-020-00397-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tollervey              JR, Curk              T, Rogelj              B, Briese              M, Cereda              M, Kayikci              M, et            al. Characterizing the RNA targets and            position-dependent splicing regulation by TDP-43. Nat            Neurosci. 2011; 14:            452\u2013458.","DOI":"10.1038\/nn.2778"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chou              CC, Zhang              Y, Umoh              ME, Vaughan              SW, Lorenzini              I, Liu              F, et            al. TDP-43 pathology disrupts nuclear pore complexes            and nucleocytoplasmic transport in ALS\/FTD. Nat            Neurosci. 2018; 21:            228\u2013239.","DOI":"10.1038\/s41593-017-0047-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Scotter              EL, Chen              HJ, Shaw              CE. Erratum to:            TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic            Targets. Neurotherapeutics. 2015;            12: 515\u2013518.","DOI":"10.1007\/s13311-015-0351-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Renton              AE, Chi\u00f2              A, Traynor              BJ. State of            play in amyotrophic lateral sclerosis genetics. Nat            Neurosci. 2014; 17:            17\u201323.","DOI":"10.1038\/nn.3584"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Suzuki              N, Nishiyama              A, Warita              H, Aoki              M. Genetics of            amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene            therapy. J Hum Genet. 2023;            68: 131\u2013152.","DOI":"10.1038\/s10038-022-01055-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Balendra              R, Sreedharan              J, Hallegger              M, Luisier              R, Lashuel              HA, Gregory              JM, et            al. Amyotrophic lateral sclerosis caused by TARDBP            mutations: from genetics to TDP-43 proteinopathy. Lancet            Neurol. 2025; 24:            456\u2013470.","DOI":"10.1016\/S1474-4422(25)00109-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tziortzouda              P, Van Den                Bosch              L, Hirth              F. Triad of            TDP43 control in neurodegeneration: autoregulation, localization and            aggregation. Nat Rev Neurosci. 2021;            22: 197\u2013208.","DOI":"10.1038\/s41583-021-00431-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Versluys              L, Ervilha                Pereira              P, Schuermans              N, De Paepe              B, De                Bleecker              JL, Bogaert              E, et            al. Expanding the TDP-43 Proteinopathy Pathway From            Neurons to Muscle: Physiological and Pathophysiological Functions.            Front Neurosci. 2022; 16:            815765.","DOI":"10.3389\/fnins.2022.815765"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gao              J, Wang              L, Huntley              ML, Perry              G, Wang              X.            Pathomechanisms of TDP-43 in neurodegeneration. J            Neurochem. 2018; 146:            7\u201320.","DOI":"10.1111\/jnc.14327"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Huang              SL, Wu              LS, Lee              M, Chang              CW, Cheng              WC, Fang              YS, et            al. A robust TDP-43 knock-in mouse model of            ALS. Acta Neuropathol Commun. 2020;            8: 3.","DOI":"10.1186\/s40478-020-0881-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Biswas              DD, Sethi              R,                Woldeyohannes              Y, Scarrow              ER, El Haddad              L, Lee              J, et            al. Respiratory pathology in the TDP-43 transgenic            mouse model of amyotrophic lateral sclerosis. Front            Physiol. 2024; 15: 1430875.","DOI":"10.3389\/fphys.2024.1430875"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ayala              YM, De Conti              L,                Avenda\u00f1o-V\u00e1zquez              SE, Dhir              A, Romano              M, D\u2019Ambrogio              A, et            al. TDP-43 regulates its mRNA levels through a            negative feedback loop. EMBO J. 2011;            30: 277\u2013288.","DOI":"10.1038\/emboj.2010.310"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sugai              A, Kato              T, Koyama              A, Koike              Y, Konno              T, Ishihara              T, et            al. Non-genetically modified models exhibit TARDBP            mRNA increase due to perturbed TDP-43 autoregulation. Neurobiol            Dis. 2019; 130: 104534.","DOI":"10.1016\/j.nbd.2019.104534"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Koyama              A, Sugai              A, Kato              T, Ishihara              T, Shiga              A, Toyoshima              Y, et            al. Increased cytoplasmic TARDBP mRNA in affected            spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.            Nucleic Acids Res. 2016; 44:            5820\u20135836.","DOI":"10.1093\/nar\/gkw499"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Polymenidou              M,                Lagier-Tourenne              C, Hutt              KR, Huelga              SC, Moran              J, Liang              TY, et            al. Long pre-mRNA depletion and RNA missplicing            contribute to neuronal vulnerability from loss of TDP-43. Nat            Neurosci. 2011; 14:            459\u2013468.","DOI":"10.1038\/nn.2779"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Avenda\u00f1o-V\u00e1zquez              SE, Dhir              A, Bembich              S, Buratti              E, Proudfoot              N, Baralle              FE.            Autoregulation of TDP-43 mRNA levels involves interplay between            transcription, splicing, and alternative polyA site selection.            Genes Dev. 2012; 26:            1679\u20131684.","DOI":"10.1101\/gad.194829.112"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sugai              A, Kato              T, Koyama              A, Koike              Y, Kasahara              S, Konno              T, et            al. Robustness and Vulnerability of the            Autoregulatory System That Maintains Nuclear TDP-43 Levels: A Trade-off Hypothesis for            ALS Pathology Based on <i>in Silico<\/i> Data. Front            Neurosci. 2018; 12: 28.","DOI":"10.3389\/fnins.2018.00028"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Austin              A, Beresford              L, Price              G, Cunningham              T, Kalmar              B, Yon              M. Sectioning            and Counting of Motor Neurons in the L3 to L6 Region of the Adult Mouse Spinal            Cord. Curr Protoc. 2022;            2: e428.","DOI":"10.1002\/cpz1.428"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schindelin              J,                Arganda-Carreras              I, Frise              E, Kaynig              V, Longair              M, Pietzsch              T, et            al. Fiji: an open-source platform for            biological-image analysis. Nat Methods.            2012; 9: 676\u2013682.","DOI":"10.1038\/nmeth.2019"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Masuya              H, Inoue              M, Wada              Y, Shimizu              A, Nagano              J, Kawai              A, et            al. Implementation of the modified-SHIRPA protocol            for screening of dominant phenotypes in a large-scale ENU mutagenesis            program. Mamm Genome. 2005;            16: 829\u2013837.","DOI":"10.1007\/s00335-005-2430-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Perea-Gomez              A, Camus              A, Moreau              A, Grieve              K, Moneron              G, Dubois              A, et            al. Initiation of gastrulation in the mouse embryo            is preceded by an apparent shift in the orientation of the anterior-posterior            axis. Curr Biol. 2004;          14: 197\u2013207.","DOI":"10.1016\/j.cub.2004.01.030"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Frey              D, Schneider              C, Xu              L, Borg              J, Spooren              W, Caroni              P. Early and            selective loss of neuromuscular synapse subtypes with low sprouting competence in            motoneuron diseases. J Neurosci. 2000;            20: 2534\u20132542.","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nijssen              J, Comley              LH, Hedlund              E. Motor neuron            vulnerability and resistance in amyotrophic lateral sclerosis.            Acta Neuropathol. 2017; 133:            863\u2013885.","DOI":"10.1007\/s00401-017-1708-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Stenson              PD, Mort              M, Ball              EV, Chapman              M, Evans              K, Azevedo              L, et            al. The Human Gene Mutation Database              (HGMD<sup>\u00ae<\/sup>): optimizing its use in a clinical diagnostic or research            setting. Hum Genet. 2020;            139: 1197\u20131207.","DOI":"10.1007\/s00439-020-02199-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Prasad              A, Bharathi              V, Sivalingam              V, Girdhar              A, Patel              BK. Molecular            mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral            sclerosis. Front Mol Neurosci. 2019;            12: 25.","DOI":"10.3389\/fnmol.2019.00025"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. de                Boer              EMJ, Orie              VK, Williams              T, Baker              MR, De                Oliveira              HM,                Polvikoski              T, et            al. TDP-43 proteinopathies: a new wave of            neurodegenerative diseases. J Neurol Neurosurg            Psychiatry. 2020; 92:            86\u201395.","DOI":"10.1136\/jnnp-2020-322983"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zeng              J, Luo              C, Jiang              Y, Hu              T, Lin              B, Xie              Y, et            al. Decoding TDP-43: the molecular chameleon of            neurodegenerative diseases. Acta Neuropathol Commun.            2024; 12: 205.","DOI":"10.1186\/s40478-024-01914-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. White              MA, Kim              E, Duffy              A, Adalbert              R, Phillips              BU, Peters              OM, et            al. TDP-43 gains function due to perturbed            autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat            Neurosci. 2018; 21:            552\u2013563.","DOI":"10.1038\/s41593-018-0113-5"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Landrum              MJ, Lee              JM, Riley              GR, Jang              W, Rubinstein              WS, Church              DM, et            al. ClinVar: public archive of relationships among            sequence variation and human phenotype. Nucleic Acids            Res. 2014; 42:            D980\u2013D985.","DOI":"10.1093\/nar\/gkt1113"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Morgan              S, Shatunov              A, Sproviero              W, Jones              AR, Shoai              M, Hughes              D, et            al. A comprehensive analysis of rare genetic            variation in amyotrophic lateral sclerosis in the UK.            Brain. 2017; 140:            1611\u20131618.","DOI":"10.1093\/brain\/awx082"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gitcho              MA, Bigio              EH, Mishra              M, Johnson              N, Weintraub              S, Mesulam              M, et            al. TARDBP 3\u2019-UTR variant in autopsy-confirmed            frontotemporal lobar degeneration with TDP-43 proteinopathy.            Acta Neuropathol. 2009; 118:            633\u2013645.","DOI":"10.1007\/s00401-009-0571-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wang              F, Fu              S, Lei              J, Wu              H, Shi              S, Chen              K, et            al. Identification of novel <i>FUS<\/i> and              <i>TARDBP<\/i> gene mutations in Chinese amyotrophic lateral sclerosis            patients with HRM analysis. Aging (Albany NY).            2020; 12: 22859\u201322868.","DOI":"10.18632\/aging.103967"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kraemer              BC, Schuck              T, Wheeler              JM, Robinson              LC,                Trojanowski              JQ, Lee              VMY, et            al. Loss of murine TDP-43 disrupts motor function            and plays an essential role in embryogenesis. Acta            Neuropathol. 2010; 119:            409\u2013419.","DOI":"10.1007\/s00401-010-0659-0"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Sephton              CF, Good              SK, Atkin              S, Dewey              CM, Mayer              P              3rd, Herz              J, et            al. TDP-43 is a developmentally regulated protein            essential for early embryonic development. J Biol Chem.            2010; 285: 6826\u20136834.","DOI":"10.1074\/jbc.M109.061846"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wu              LS, Cheng              WC, Hou              SC, Yan              YT, Jiang              ST, Shen              CKJ. TDP-43, a            neuro-pathosignature factor, is essential for early mouse embryogenesis.            Genesis. 2010; 48:            56\u201362.","DOI":"10.1002\/dvg.20584"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/75\/1\/75_25-0061\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:14:12Z","timestamp":1767413652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/75\/1\/75_25-0061\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.25-0061","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0061"}}